FDA approved Cubist's treatment for skin infections including MRSA.

NIH launched 3D Print Exchange, a public website promoting health and science applications of 3D printing.

Shire reports that AbbVie offer undervalued company.

Dr. Reddy's recalls blood pressure drug due to failed dissolution tests.

FDA cites cGMP violations for API manufacturing at a facility in Tianjin, China.

Big pharma employment dropped by 3% between 2003 and 2013, according to a new jobs report published by EP Vantage.

New services manage clinical or drug manufacturing data in the Verizon cloud or from data centers.

Arecor and the Center for Process Innovation (CPI) Biologics are working on a project to enhance the compatibility of biologics with their containers.

FDA inspection found cGMP violations in the Bangalore, India API manufacturing facility.

The National Institutes of Health and the National Science Foundation set up biomedical innovation and business program.

EDQM details the agency?s accomplishments in 2013.

FDA issues guidance on the use of social media in regards to prescription drugs.

ISPE Metrics Pilot Program is designed to demonstrate the feasibility and value of standard quality metrics.

Funding boosts life-sciences manufacturing in West Michigan.

FDA provides advice to supply-chain stakeholders on how to identify suspect drug products and how to notify the agency of those products.

Novartis facility becomes the first US site licensed by the FDA to produce cell-culture influenza vaccines.

Catalent and AAPS announce the five winners of its annual academic competition.

EMA has published a new guidance template for the qualified person’s declaration concerning GMP compliance of API manufacture. The QP declaration template provides the basis for demonstrating compliance of the API manufacture with GMP requirements and ensures that the manufacturer has sufficient knowledge on the supply chain.

The fabrication facility will supply modular construction to the US life-science market.

The new mAb manufacturing facility in Switzerland will supply material for clinical development.

Draft guidance from FDA includes information essential for the completion of ANDA applications.

A new report from GlobalData states that biosimilars will overtake the market share after 2019.

USP and USAID give prequalification status to Capreomycin, an anti-tuberculosis injectable.

Merck acquires Idenix Pharmaceuticals for $3.85 billion.

Cellectis enters an agreement with CELLforCURE for cGMP clinical manufacturing of allogeneic T-cells.

Xcelience opens a clinical packaging and distribution facility in Birmingham, UK.

APIC provides guidance on cleaning validation in API plants and how to implement GDP for APIs.

Eleven new organizations join the global "Fight the Fakes" campaign.